Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
|
CN |
|
M
|
Meyar Co
SAU:9565
|
SA |
|
L
|
LX Technology Group Ltd
HKEX:2436
|
CN |
|
Gamma Communications PLC
LSE:GAMA
|
UK |
|
S
|
Substrate Artificial Inteligence SA
MAD:SAI
|
ES |
|
Brunswick Exploration Inc
XTSX:BRW
|
CA |
|
Nandan Denim Ltd
NSE:NDL
|
IN |
|
S
|
Smart Metering Systems PLC
F:SMC
|
UK |
|
U
|
United Homes Group Inc
NASDAQ:UHG
|
US |
|
Shaver Shop Group Ltd
ASX:SSG
|
AU |
|
I
|
IBI Investment House Ltd
TASE:IBI
|
IL |
|
HK Electric Investments Ltd
OTC:HKVTY
|
HK |
|
A
|
AMTD IDEA Group
SGX:HKB
|
HK |
|
B
|
BSL Ltd
NSE:BSL
|
IN |
|
Nissin Foods Co Ltd
HKEX:1475
|
HK |
|
W
|
Western Superconducting Technologies Co Ltd
SSE:688122
|
CN |
|
Citizens Financial Group Inc
NYSE:CFG
|
US |
|
U
|
UniVision Engineering Ltd
LSE:UVEL
|
HK |
|
GI Technologies Group Co Ltd
SZSE:300309
|
CN |
Wall Street
Price Targets
Price Targets Summary
Shandong Weigao Blood Purification Products Co Ltd
According to Wall Street analysts, the average 1-year price target for Shandong Weigao Blood Purification Products Co Ltd is 46.62 CNY with a low forecast of 45.36 CNY and a high forecast of 48.83 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shandong Weigao Blood Purification Products Co Ltd's stock price target?
Price Target
46.62
CNY
According to Wall Street analysts, the average 1-year price target for Shandong Weigao Blood Purification Products Co Ltd is 46.62 CNY with a low forecast of 45.36 CNY and a high forecast of 48.83 CNY.
What is Shandong Weigao Blood Purification Products Co Ltd's Revenue forecast?
Projected CAGR
8%
For the last 1 year the compound annual growth rate for Shandong Weigao Blood Purification Products Co Ltd's revenue is 2%. The projected CAGR for the next 3 years is 8%.
What is Shandong Weigao Blood Purification Products Co Ltd's Operating Income forecast?
Projected CAGR
9%
For the last 1 year the compound annual growth rate for Shandong Weigao Blood Purification Products Co Ltd's operating income is 3%. The projected CAGR for the next 3 years is 9%.
What is Shandong Weigao Blood Purification Products Co Ltd's Net Income forecast?
Projected CAGR
9%
For the last 1 year the compound annual growth rate for Shandong Weigao Blood Purification Products Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 9%.
